Historical version

This is version 1, as it stood on . It is not what this organization currently publishes — read the current version.

Anvisa registra duas novas canetas de semaglutida

Imported from official source

Produtos são indicados para o tratamento de obesidade e têm como matriz o medicamento Owozy

This version

Version
1 of 2
Recorded
November 10, 2026 13:02
Change
Initial
Content hash
b0df3de653804f72cc91ac61ba8a8915
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.